Author

Meenakshi Mendiratta

Observed name: Mendiratta, Meenakshi

Institutions: DR. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences

Observed institutions: DR. B.R.A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences

ORCID: 0009-0000-2768-1713

Observed ORCID: 0009-0000-2768-1713

OpenAlex ID: A5069521955

Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model

2024 · Mohini Mendiratta, Meenakshi Mendiratta, et al. · Stem Cell Research & Therapy · 13

Breaking the graft-versus-host-disease barrier: Mesenchymal stromal/stem cells as precision healers

2023 · Mohini Mendiratta, Meenakshi Mendiratta, et al. · International Reviews of Immunology · 11

Uncovering the bequeathing potential of apoptotic mesenchymal stem cells via small extracellular vesicles for its enhanced immunomodulatory and regenerative ability

2025 · Meenakshi Mendiratta, Mohini Mendiratta, et al. · Stem Cell Research & Therapy · 5

Hypoxia-Mediated Molecular Interactions of Tissue-Specific Mesenchymal Stem Cells Drive Metabolic Reprogramming and Immunomodulation in Acute Graft-versus-Host Disease

2025 · Mohini Mendiratta, Meenakshi Mendiratta, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 5

The Integral Role of Mesenchymal Stem Cells in Stem Cell Transplantation from Promotion of Stem Cell Engraftment to Immunomodulation

2024 · Mohini Mendiratta, Meenakshi Mendiratta, et al. · Biochemistry · 3

Therapeutic Prospects of Stem Cell-Derived EVs: Upcoming Avenues, Promises, and Challenges

2024 · Yashvi Sharma, Meenakshi Mendiratta, et al. · Springer eBooks · 3

A Comparative assessment of T-Cell response of Healthy donors and Acute Graft-versus-Host-Disease Patients: Customizing immune monitoring platform

2024 · Mohini Mendiratta, Meenakshi Mendiratta, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

Hypoxia-induced metabolic and apoptotic reprogramming enhances immunomodulation in Wharton’s jelly mesenchymal stem cells

2026 · Mohini Mendiratta, Meenakshi Mendiratta, et al. · iScience · 1

Cytokine Signatures Outperform Immune Subsets in Machine Learning Models for Predicting Acute Graft‐Versus‐Host Disease at Neutrophil Engraftment

2026 · Mohini Mendiratta, Praful Pandey, et al. · Journal of Immunology Research · 1

Dose-response immunomodulatory effects of Mesenchymal stem cell-derived culture-conditioned media in acute Graft-versus-Host Disease

2025 · Mohini Mendiratta, Meenakshi Mendiratta, et al. · Regenerative Therapy · 1

One‐Step Freeze Drying Strategy for Scalable Production of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells

2025 · Yashvi Sharma, Meenakshi Mendiratta, et al. · Advanced Therapeutics · 1

An overview on mesenchymal stem cells and extracellular vesicles in regenerative medicine

2026 · Meenakshi Mendiratta, Mayank Kashyap, et al. · Elsevier eBooks

Dual Preconditioned Mesenchymal Stem Cells-Derived Culture Conditioned Media Augment Immunomodulation and Drive Metabolic Reprogramming in Acute Graft-versus-Host Disease

2025 · Mohini Mendiratta, Meenakshi Mendiratta, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Secretome of Hypoxia-Preconditioned Apoptotic Wharton's Jelly Mesenchymal Stem Cells: A Superior Non-Cellular Approach for Managing Acute Graft-Versus-Host Disease

2025 · Ranjit Kumar Sahoo, Mohini Mendiratta, et al. · Transplantation and Cellular Therapy

Works count: 18

Citation count: 46

H-index: 4

I10-index: 2